Preliminary results of a Phase 3, randomized, placebo-controlled clinical trial testing the investigative monoclonal antibody LY-CoV555 in hospitalized COVID-19 patients were published today in The New England Journal of Medicine.
National Institutes of Health researchers have isolated a set of promising, tiny antibodies, or “nanobodies,” against SARS-CoV-2 that were produced by a llama named Cormac.
Retractions and controversies over coronavirus research show that the process of science is working as it should
Several high-profile papers on COVID-19 research have come under fire from people in the scientific community in recent weeks. Two articles addressing the safety of certain drugs when taken by COVID-19 patients were retracted, and researchers are calling for the retraction of a third paper that evaluated behaviors that mitigate coronavirus transmission.
Global scientific community unites to track progress on COVID-19 R&D, identifies new research priorities and critical gaps
The World Health Organization held a two half-day virtual summit on 1 and 2 July, to take stock of the evolving science on COVID-19 and examine progress made so far in developing effective health tools to improve the global response to the pandemic.
Unprecedented gathering of heads of government, institutions and industry cements commitment to accelerate development and delivery for all populations
Heads of state and global health leaders today made an unprecedented commitment to work together to accelerate the development and production of new vaccines, tests and treatments for COVID-19 and assure equitable access worldwide.
The National Institutes of Health announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic.
While the world battles COVID-19 as the virus devastates countries and crippling businesses the world over, we will be dealing with a new phase of social lifestyles that will again haunt the recuperation of the already fallen businesses hoping to find their way back in post COVID-19 pandemic.